Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Jéru I[au]:

Familial autoinflammation with neutrophilic dermatosis reveals a regulatory mechanism of pyrin activation. Masters SL et al. Sci Transl Med. (2016)

Cytokine signatures in hereditary fever syndromes (HFS). Ibrahim JN et al. Cytokine Growth Factor Rev. (2017)

Clinical Utility Gene Card for: Familial partial lipodystrophy. Jéru I et al. Eur J Hum Genet. (2017)

Search results

Items: 39

1.

Genetic contribution of ABCC2 to Dubin-Johnson syndrome and inherited cholestatic disorders.

Corpechot C, Barbu V, Chazouillères O, Broué P, Girard M, Roquelaure B, Chrétien Y, Dong C, Lascols O, Housset C, Jéru I.

Liver Int. 2019 Sep 22. doi: 10.1111/liv.14260. [Epub ahead of print]

PMID:
31544333
2.

Diagnostic Challenge in PLIN1-Associated Familial Partial Lipodystrophy.

Jéru I, Vantyghem MC, Bismuth E, Cervera P, Barraud S; PLIN1-Study Group, Auclair M, Vatier C, Lascols O, Savage DB, Vigouroux C.

J Clin Endocrinol Metab. 2019 Dec 1;104(12):6025-6032. doi: 10.1210/jc.2019-00849.

PMID:
31504636
3.

Update on the Genetics of Autoinflammatory Disorders.

Jéru I.

Curr Allergy Asthma Rep. 2019 Jul 18;19(9):41. doi: 10.1007/s11882-019-0874-2. Review.

PMID:
31321571
4.

Adherence with metreleptin therapy and health self-perception in patients with lipodystrophic syndromes.

Vatier C, Kalbasi D, Vantyghem MC, Lascols O, Jéru I, Daguenel A, Gautier JF, Buyse M, Vigouroux C.

Orphanet J Rare Dis. 2019 Jul 12;14(1):177. doi: 10.1186/s13023-019-1141-2.

5.

Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies.

Wahbi K, Ben Yaou R, Gandjbakhch E, Anselme F, Gossios T, Lakdawala NK, Stalens C, Sacher F, Babuty D, Trochu JN, Moubarak G, Savvatis K, Porcher R, Laforêt P, Fayssoil A, Marijon E, Stojkovic T, Béhin A, Leonard-Louis S, Sole G, Labombarda F, Richard P, Metay C, Quijano-Roy S, Dabaj I, Klug D, Vantyghem MC, Chevalier P, Ambrosi P, Salort E, Sadoul N, Waintraub X, Chikhaoui K, Mabo P, Combes N, Maury P, Sellal JM, Tedrow UB, Kalman JM, Vohra J, Androulakis AFA, Zeppenfeld K, Thompson T, Barnerias C, Bécane HM, Bieth E, Boccara F, Bonnet D, Bouhour F, Boulé S, Brehin AC, Chapon F, Cintas P, Cuisset JM, Davy JM, De Sandre-Giovannoli A, Demurger F, Desguerre I, Dieterich K, Durigneux J, Echaniz-Laguna A, Eschalier R, Ferreiro A, Ferrer X, Francannet C, Fradin M, Gaborit B, Gay A, Hagège A, Isapof A, Jeru I, Juntas Morales R, Lagrue E, Lamblin N, Lascols O, Laugel V, Lazarus A, Leturcq F, Levy N, Magot A, Manel V, Martins R, Mayer M, Mercier S, Meune C, Michaud M, Minot-Myhié MC, Muchir A, Nadaj-Pakleza A, Péréon Y, Petiot P, Petit F, Praline J, Rollin A, Sabouraud P, Sarret C, Schaeffer S, Taithe F, Tard C, Tiffreau V, Toutain A, Vatier C, Walther-Louvier U, Eymard B, Charron P, Vigouroux C, Bonne G, Kumar S, Elliott P, Duboc D.

Circulation. 2019 Jul 23;140(4):293-302. doi: 10.1161/CIRCULATIONAHA.118.039410. Epub 2019 Jun 3.

PMID:
31155932
6.

Monogenic forms of lipodystrophic syndromes: diagnosis, detection, and practical management considerations from clinical cases.

Vatier C, Vantyghem MC, Storey C, Jéru I, Christin-Maitre S, Fève B, Lascols O, Beltrand J, Carel JC, Vigouroux C, Bismuth E.

Curr Med Res Opin. 2019 Mar;35(3):543-552. doi: 10.1080/03007995.2018.1533459. Epub 2018 Nov 9.

7.

MFN2-associated lipomatosis: Clinical spectrum and impact on adipose tissue.

Capel E, Vatier C, Cervera P, Stojkovic T, Disse E, Cottereau AS, Auclair M, Verpont MC, Mosbah H, Gourdy P, Barraud S, Miquel A, Züchner S, Bonnefond A, Froguel P, Christin-Maitre S, Delemer B, Fève B, Laville M, Robert J, Tenenbaum F, Lascols O, Vigouroux C, Jéru I.

J Clin Lipidol. 2018 Nov - Dec;12(6):1420-1435. doi: 10.1016/j.jacl.2018.07.009. Epub 2018 Jul 25.

PMID:
30158064
8.

Lipodystrophic syndromes due to LMNA mutations: recent developments on biomolecular aspects, pathophysiological hypotheses and therapeutic perspectives.

Vigouroux C, Guénantin AC, Vatier C, Capel E, Le Dour C, Afonso P, Bidault G, Béréziat V, Lascols O, Capeau J, Briand N, Jéru I.

Nucleus. 2018 Jan 1;9(1):235-248. doi: 10.1080/19491034.2018.1456217. Review.

9.

LMNA-associated partial lipodystrophy: anticipation of metabolic complications.

Jeru I, Vatier C, Vantyghem MC, Lascols O, Vigouroux C.

J Med Genet. 2017 Jun;54(6):413-416. doi: 10.1136/jmedgenet-2016-104437. Epub 2017 Apr 13.

PMID:
28408391
10.

Cytokine signatures in hereditary fever syndromes (HFS).

Ibrahim JN, Jéru I, Lecron JC, Medlej-Hashim M.

Cytokine Growth Factor Rev. 2017 Feb;33:19-34. doi: 10.1016/j.cytogfr.2016.11.001. Epub 2016 Nov 22. Review.

PMID:
27916611
11.

Clinical Utility Gene Card for: Familial partial lipodystrophy.

Jéru I, Vatier C, Araujo-Vilar D, Vigouroux C, Lascols O.

Eur J Hum Genet. 2017 Feb;25(2). doi: 10.1038/ejhg.2016.102. Epub 2016 Aug 3. No abstract available.

12.

Clinical Utility Gene Card for: Congenital Generalized Lipodystrophy.

Jéru I, Vatier C, Araujo-Vilar D, Vigouroux C, Lascols O.

Eur J Hum Genet. 2016 Nov;24(11). doi: 10.1038/ejhg.2016.53. Epub 2016 May 18. No abstract available.

13.

Familial autoinflammation with neutrophilic dermatosis reveals a regulatory mechanism of pyrin activation.

Masters SL, Lagou V, Jéru I, Baker PJ, Van Eyck L, Parry DA, Lawless D, De Nardo D, Garcia-Perez JE, Dagley LF, Holley CL, Dooley J, Moghaddas F, Pasciuto E, Jeandel PY, Sciot R, Lyras D, Webb AI, Nicholson SE, De Somer L, van Nieuwenhove E, Ruuth-Praz J, Copin B, Cochet E, Medlej-Hashim M, Megarbane A, Schroder K, Savic S, Goris A, Amselem S, Wouters C, Liston A.

Sci Transl Med. 2016 Mar 30;8(332):332ra45. doi: 10.1126/scitranslmed.aaf1471.

14.

On-demand treatment with anakinra: a treatment option for selected TRAPS patients.

Grimwood C, Despert V, Jeru I, Hentgen V.

Rheumatology (Oxford). 2015 Sep;54(9):1749-51. doi: 10.1093/rheumatology/kev111. Epub 2015 Jun 14. No abstract available.

PMID:
26078218
15.

Brief Report: Involvement of TNFRSF11A molecular defects in autoinflammatory disorders.

Jéru I, Cochet E, Duquesnoy P, Hentgen V, Copin B, Mitjavila-Garcia MT, Sheykholeslami S, Le Borgne G, Dastot-Le Moal F, Malan V, Karabina S, Mahevas M, Chantot-Bastaraud S, Lecron JC, Faivre L, Amselem S.

Arthritis Rheumatol. 2014 Sep;66(9):2621-7. doi: 10.1002/art.38727.

16.

Involvement of the same TNFR1 residue in mendelian and multifactorial inflammatory disorders.

Jéru I, Charmion S, Cochet E, Copin B, Duquesnoy P, Garcia MT, Le Borgne G, Cathebras P, Gaillat J, Karabina S, Dodé C, Lohse P, Hentgen V, Amselem S.

PLoS One. 2013 Jul 24;8(7):e69757. doi: 10.1371/journal.pone.0069757. Print 2013.

17.

The risk of familial Mediterranean fever in MEFV heterozygotes: a statistical approach.

Jéru I, Hentgen V, Cochet E, Duquesnoy P, Le Borgne G, Grimprel E, Stojanovic KS, Karabina S, Grateau G, Amselem S.

PLoS One. 2013 Jul 3;8(7):e68431. doi: 10.1371/journal.pone.0068431. Print 2013.

18.

How should we approach classification of autoinflammatory diseases?

Grateau G, Hentgen V, Stojanovic KS, Jéru I, Amselem S, Steichen O.

Nat Rev Rheumatol. 2013 Oct;9(10):624-9. doi: 10.1038/nrrheum.2013.101. Epub 2013 Jul 9. Review.

PMID:
23838615
19.

Atypical presentation of a cryopyrin-associated periodic syndrome, revealing a novel NLRP3 mutation.

Canouï E, Maigné G, Jéru I, Amselem S, Koné-Paut I, Lambotte O.

Clin Immunol. 2013 Aug;148(2):299-300. doi: 10.1016/j.clim.2013.05.020. Epub 2013 Jun 12. No abstract available.

20.

Familial Mediterranean fever in heterozygotes: are we able to accurately diagnose the disease in very young children?

Hentgen V, Grateau G, Stankovic-Stojanovic K, Amselem S, Jéru I.

Arthritis Rheum. 2013 Jun;65(6):1654-62. doi: 10.1002/art.37935.

21.

Dramatic beneficial effect of interleukin-1 inhibitor treatment in patients with familial Mediterranean fever complicated with amyloidosis and renal failure.

Stankovic Stojanovic K, Delmas Y, Torres PU, Peltier J, Pelle G, Jéru I, Colombat M, Grateau G.

Nephrol Dial Transplant. 2012 May;27(5):1898-901. doi: 10.1093/ndt/gfr528. Epub 2011 Sep 19.

PMID:
21931121
22.

The regulation of MEFV expression and its role in health and familial Mediterranean fever.

Grandemange S, Aksentijevich I, Jeru I, Gul A, Touitou I.

Genes Immun. 2011 Oct;12(7):497-503. doi: 10.1038/gene.2011.53. Epub 2011 Jul 21. Review.

PMID:
21776013
23.

Identification and functional consequences of a recurrent NLRP12 missense mutation in periodic fever syndromes.

Jéru I, Le Borgne G, Cochet E, Hayrapetyan H, Duquesnoy P, Grateau G, Morali A, Sarkisian T, Amselem S.

Arthritis Rheum. 2011 May;63(5):1459-64. doi: 10.1002/art.30241.

24.

Role of interleukin-1β in NLRP12-associated autoinflammatory disorders and resistance to anti-interleukin-1 therapy.

Jéru I, Hentgen V, Normand S, Duquesnoy P, Cochet E, Delwail A, Grateau G, Marlin S, Amselem S, Lecron JC.

Arthritis Rheum. 2011 Jul;63(7):2142-8. doi: 10.1002/art.30378.

25.

Mutations in the autoinflammatory cryopyrin-associated periodic syndrome gene: epidemiological study and lessons from eight years of genetic analysis in France.

Cuisset L, Jeru I, Dumont B, Fabre A, Cochet E, Le Bozec J, Delpech M, Amselem S, Touitou I; French CAPS study group.

Ann Rheum Dis. 2011 Mar;70(3):495-9. doi: 10.1136/ard.2010.138420. Epub 2010 Nov 24. Erratum in: Ann Rheum Dis. 2012 Jul;71(7):1264. Lemelle, C [corrected to Lemelle, I].

PMID:
21109514
26.

[Inflammasome and interleukin 1].

Jéru I, Amselem S.

Rev Med Interne. 2011 Apr;32(4):218-24. doi: 10.1016/j.revmed.2010.02.013. Epub 2010 Jun 11. French.

PMID:
20541850
27.

Functional consequences of a germline mutation in the leucine-rich repeat domain of NLRP3 identified in an atypical autoinflammatory disorder.

Jéru I, Marlin S, Le Borgne G, Cochet E, Normand S, Duquesnoy P, Dastot-Le Moal F, Cuisset L, Hentgen V, Fernandes Alnemri T, Lecron JC, Dhote R, Grateau G, Alnemri ES, Amselem S.

Arthritis Rheum. 2010 Apr;62(4):1176-85. doi: 10.1002/art.27326.

28.

Involvement of the modifier gene of a human Mendelian disorder in a negative selection process.

Jéru I, Hayrapetyan H, Duquesnoy P, Cochet E, Serre JL, Feingold J, Grateau G, Sarkisian T, Jeanpierre M, Amselem S.

PLoS One. 2009 Oct 30;4(10):e7676. doi: 10.1371/journal.pone.0007676.

29.

[Molecular bases of hereditary recurrent fevers].

Jéru I, Grateau G, Amselem S.

Pathol Biol (Paris). 2009 May;57(3):213-6. doi: 10.1016/j.patbio.2008.04.008. Epub 2008 Jun 13. French. No abstract available.

PMID:
18554823
30.

Mutations in NALP12 cause hereditary periodic fever syndromes.

Jéru I, Duquesnoy P, Fernandes-Alnemri T, Cochet E, Yu JW, Lackmy-Port-Lis M, Grimprel E, Landman-Parker J, Hentgen V, Marlin S, McElreavey K, Sarkisian T, Grateau G, Alnemri ES, Amselem S.

Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1614-9. doi: 10.1073/pnas.0708616105. Epub 2008 Jan 29.

31.

PYPAF1 nonsense mutation in a patient with an unusual autoinflammatory syndrome: role of PYPAF1 in inflammation.

Jéru I, Hayrapetyan H, Duquesnoy P, Sarkisian T, Amselem S.

Arthritis Rheum. 2006 Feb;54(2):508-14.

32.

Interaction of pyrin with 14.3.3 in an isoform-specific and phosphorylation-dependent manner regulates its translocation to the nucleus.

Jéru I, Papin S, L'hoste S, Duquesnoy P, Cazeneuve C, Camonis J, Amselem S.

Arthritis Rheum. 2005 Jun;52(6):1848-57.

33.

Amyloidosis and auto-inflammatory syndromes.

Grateau G, Jéru I, Rouaghe S, Cazeneuve C, Ravet N, Duquesnoy P, Cuisset L, Dodé C, Delpech M, Amselem S.

Curr Drug Targets Inflamm Allergy. 2005 Feb;4(1):57-65. Review.

PMID:
15720237
34.
35.
36.

[The role of zinc in the appearance of cataract].

Jeru I.

Oftalmologia. 1997;41(4):329-32. Romanian.

PMID:
9409986
37.

[The treatment of penetrating eye injuries].

Lupaşco V, Boiştean V, Blanunţa T, Jeru I.

Oftalmologia. 1997;41(3):245-6. Romanian.

PMID:
9409972
38.

[Biochemical aspects in the pathogenesis of senile cataract].

Jeru I, Boiştean V, Lupaşco V.

Oftalmologia. 1997;41(3):207-8. Romanian.

PMID:
9409962
39.

[The characteristics of the pathogenesis and immunomodulator treatment in the postoperative period in pseudophakia patients].

Boiştean V, Jeru I, Lupaşco V.

Oftalmologia. 1996 Jul-Sep;40(3):210-3. Romanian.

PMID:
8962845

Supplemental Content

Support Center